Immunophenotypic, cytotoxic, proteomic and genomic characterization of human cord blood vs. peripheral blood CD56 NK cells von Evan Shereck, Nancy S Day, Aradhana Awasthi, Janet Ayello, Yaya Chu, Catherine McGuinn, Carmella van de Ven, Megan S Lim, Mitchell S Cairo

Volltext

Immunophenotypic, cytotoxic, proteomic and genomic characterization of human cord blood vs. peripheral blood CD56Dim NK cells von Shereck, Evan, Day, Nancy S, Awasthi, Aradhana, Ayello, Janet, Chu, Yaya, McGuinn, Catherine, van de Ven, Carmella, Lim, Megan S, Cairo, Mitchell S

Volltext

Rap1b facilitates NK cell functions via IQGAP1-mediated signalosomes von Awasthi, Aradhana, Samarakoon, Asanga, Chu, Haiyan, Kamalakannan, Rajasekaran, Quilliam, Lawrence A, Chrzanowska-Wodnicka, Magdalena, White, 2nd, Gilbert C, Malarkannan, Subramaniam

Volltext

Abstract 2381: Blinatumomab enhanced anti-tumor activity against rituximab sensitive and resistant Burkitt Lymphoma (BL) and Primary Mediastinal B-cell Lymphoma (PMBL) von Tiwari, Aradhana Awasthi, Edani, Dina, Ayello, Janet, Cairo, Mitchell S.

Volltext

Abstract 1537: Polatuzumab Vedotin alone or in-combination with anti-CD20 antibody significantly enhanced overall survival in xenografted NSG mice against rituximab sensitive and r... von Tiwari, Aradhana Awasthi, Edani, Dina, Ayello, Janet, Klein, Christian, Cairo, Mitchell S.

Volltext

Obinutuzumab (GA101) compared to rituximab significantly enhances cell death and antibody‐dependent cytotoxicity and improves overall survival against CD20+ rituximab‐sensitive/‐re... von Awasthi, Aradhana, Ayello, Janet, Van de Ven, Carmella, Elmacken, Mona, Sabulski, Anthony, Barth, Matthew J., Czuczman, Myron S., Islam, Humayun, Klein, Christian, Cairo, Mitchell S.

Volltext

Abstract 1788: Enhanced in vitro/in vivo cytotoxicity against Burkitt lymphoma/primary mediastinal large B cell lymphoma by polatuzumab vedotin (hu- anti-CD79b-vc-MMAE, PV) alone o... von Tiwari, Aradhana Awasthi, Edani, Dina, Azmy, Christeen, Ayello, Janet, Klein, Christian, Cairo, Mitchell S.

Volltext

Abstract 2657: PD-L1 blockade enhances T cell cytotoxicity against primary mediastinal B cell lymphoma von Shah, Tishi, Luo, Wen, Awasthi, Aradhana, Ayello, Janet, Hochberg, Jessica, Cairo, Mitchell

Volltext

Abstract 2565: EBV peptide-derived vaccine significantly enhanced in vitro cytotoxicity against EBV-positive B-cell lymphoma (EBV-BL) treatment using TMV-based delivery system von Tiwari, Aradhana Awasthi, McCormick, Alison, Edani, Dina, Newman, Aaron, Azmy, Christeen, Ayello, Janet, Klein, Christian, Cairo, Mitchell S.

Volltext

Polatuzumab Vedotin; Antibody Drug Conjugates (ADC, anti-CD79b-vc-MMAE, PV) Significantly Enhances in-Vitro Cell Death Against CD79b+ Burkitt Lymphoma (BL) /Primary Mediastinal Lar... von Awasthi, Aradhana, Ayello, Janet, van de Ven, Carmella, Love, Asana, Cairo, Mitchell S.

Volltext

Amyloid-beta causes apoptosis of neuronal cells via caspase cascade, which can be prevented by amyloid-beta-derived short peptides von Awasthi, Aradhana, Matsunaga, Yoichi, Yamada, Tatsuo

Volltext

Obinutuzumab (GA101) vs. rituximab significantly enhances cell death, antibody-dependent cytotoxicity and improves overall survival against CD20+ primary mediastinal B-cell lymphom... von Chu, Yaya, Awasthi, Aradhana, Lee, Sanghoon, Edani, Dina, Yin, Changhong, Hochberg, Jessica, Shah, Tishi, Chung, Tae-Hoon, Ayello, Janet, Ven, Carmella van de, Klein, Christian, Lee, Dean, Cairo, Mitchell S.

Volltext

Can we distinguish pneumonia from wheezy diseases in tachypnoeic children under low-resource conditions? A prospective observational study in four Indian hospitals von GOWRAIAH, Vishwanath, AWASTHI, Shally, KAPOOR, Rashmi, SAHANA, Devdas, VENKATESH, Pushpalatha, GANGADHAR, Belvadi, AWASTHI, Aradhana, VERMA, Anilkumar, PAI, Nanditha, SEEAR, Michael

Volltext

Immunophenotypic, cytotoxic, proteomic and genomic characterization of human cord blood vs. peripheral blood CD56 Dim NK cells von Shereck, Evan, Day, Nancy S, Awasthi, Aradhana, Ayello, Janet, Chu, Yaya, McGuinn, Catherine, van de Ven, Carmella, Lim, Megan S, Cairo, Mitchell S

Volltext

IQGAP1: a regulator of intracellular spacetime relativity von Malarkannan, Subramaniam, Awasthi, Aradhana, Rajasekaran, Kamalakannan, Kumar, Pawan, Schuldt, Kristina M, Bartoszek, Allison, Manoharan, Niranjan, Goldner, Nicholas K, Umhoefer, Colleen M, Thakar, Monica S

Volltext

Abstract 3155: Neuroblastoma (NB), Medulloblastoma (MB), and Ewing's sarcoma (ES) express ROR1 and can be effectively targeted with NK cells modified to express an anti ROR1 chimer... von Elmacken, Mona, Awasthi, Aradhana, Ayello, Janet, VanDeVen, Carmella, Luo, Wen, Liao, Yanling, Riddell, Stanley, Cairo, Mitchell S.

Volltext

Abstract 2479: Obinutuzumab compared to Rituximab significantly enhances cell death, antibody dependent cytotoxicity (ADCC) and improves overall survival against CD20+ rituximab-se... von Tiwari, Aradhana Awasthi, Ayello, Janet, Vandeven, Carmella, Elmacken, Mona, Barth, Matthew J., Klein, Christian, Cairo, Mitchell S.

Volltext

Abstract 579: Antibody drug conjugates (anti-CD79b-vc-MMAE, Polatuzumab Vedotin) exhibit enhanced cell death targeted to CD79b+ Burkitt lymphoma (BL) and primary mediastinal large... von Tiwari, Aradhana Awasthi, Ayello, Janet, van de Ven, Carmella, Kurien, Lisa, Barth, Matthew J., Cairo, Mitchell S.

Volltext

Comparative Study of Obinutuzumab (GA101) Vs. Rituximab Against CD20+ rituximab-Sensitive and -Resistant Burkitt (BL) and Acute Lymphoblastic Leukemia (B-ALL): Potential Targeted T... von Awasthi, Aradhana, Ayello, Janet, van de Ven, Carmella, Elmacken, Mona, Reggio, Christopher, Barth, Matthew J., Cairo, Mitchell S.

Volltext

Obinutuzumab (GA101) Significantly Improves Survival In CD20 Positive Pre-B Cell Lymphoblastic Leukemia (pre-B-ALL) Xenograft Models Compared To Rituximab (RTX): Potential Targeted... von Awasthi, Aradhana, Ayello, Janet, Ven, Carmella van de, Hovy, Stefan, Cairo, Mitchell S.

Volltext